Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Toronto

$135,000.00

Exploring Needs, Concerns, and Research Priorities Regarding Prophylactic Doxycycline Use Among Gay, Bisexual, Queer Men and Gender Diverse People

FY 2023-24

Summary
Gay, bisexual, and queer men (GBQM) and gender diverse people, including Two-Spirit, transgender, and nonbinary folks are disproportionately affected by HIV and other sexually transmitted infections (STIs) in Canada. In recent studies, doxycycline, a commonly used antibiotic, has been tested to prevent bacterial STIs (i.e., prescribed before being tested for the STI), showing evidence of reducing the chance of infection among GBQM and trans women. Despite the growing research, the medical and GBQM and gender diverse communities across Canada will vary in acceptance and willingness to use such preventative treatment. A concern for antimicrobial resistance (AMR) remains, which could make it harder to treat other types of infections. There is little research from other interested parties from the health system (other than doctors) that explore preventative use of doxycycline among GBQM and gender diverse people. Further, the debate about using antibiotics to prevent STIs and concerns for AMR, as well as lack of consistent guidelines to govern prescribing practices, result in a need for more clarity. This is a proposed expanded sub-study of the Engage 2.0 Study, which is a mixed-methods cohort study collecting data from GBQM in Vancouver, Toronto, and Montreal. The purpose of the proposed study is to explore GBQM's, gender diverse people's, and health system stakeholders' needs, concerns, and research priorities related to the preventative use of doxycycline. This study involves four phases, including (1) a rapid review and synthesis of the research and guidelines; (2) focus groups with health system stakeholders; (3) interviews with community members; and (4) knowledge mobilization. This study will inform the data collection phases of the Engage 2.0 Study, as well as develop recommendations for future work (e.g., research priorities, policy statements, sexual health programs).
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
492457
Name
Vo Tin D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Exploring Needs, Concerns, and Research Priorities Regarding Prophylactic Doxycycline Use Among Gay, Bisexual, Queer Men and Gender Diverse People
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Antimicrobial Resistance; Doxycycline Prophylactic Use; Gay, Bisexual, Queer, And Other Men Who Have Sex With Men; Health Equity; Health System; Qualitative Research; Sexual Health Promotion; Sti Prevention
Abstract
Gay, bisexual, and queer men (GBQM) and gender diverse people, including Two-Spirit, transgender, and nonbinary folks are disproportionately affected by HIV and other sexually transmitted infections (STIs) in Canada. In recent studies, doxycycline, a commonly used antibiotic, has been tested to prevent bacterial STIs (i.e., prescribed before being tested for the STI), showing evidence of reducing the chance of infection among GBQM and trans women. Despite the growing research, the medical and GBQM and gender diverse communities across Canada will vary in acceptance and willingness to use such preventative treatment. A concern for antimicrobial resistance (AMR) remains, which could make it harder to treat other types of infections. There is little research from other interested parties from the health system (other than doctors) that explore preventative use of doxycycline among GBQM and gender diverse people. Further, the debate about using antibiotics to prevent STIs and concerns for AMR, as well as lack of consistent guidelines to govern prescribing practices, result in a need for more clarity. This is a proposed expanded sub-study of the Engage 2.0 Study, which is a mixed-methods cohort study collecting data from GBQM in Vancouver, Toronto, and Montreal. The purpose of the proposed study is to explore GBQM's, gender diverse people's, and health system stakeholders' needs, concerns, and research priorities related to the preventative use of doxycycline. This study involves four phases, including (1) a rapid review and synthesis of the research and guidelines; (2) focus groups with health system stakeholders; (3) interviews with community members; and (4) knowledge mobilization. This study will inform the data collection phases of the Engage 2.0 Study, as well as develop recommendations for future work (e.g., research priorities, policy statements, sexual health programs).
Competitiondate
202310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Vo, Tin D
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~
University of Toronto - $135,000 Grant (2023-24) | Canada Spends